CDC: 2021 to 2022 Saw Increase in U.S. Life Expectancy
By Elana Gotkine HealthDay Reporter
WEDNESDAY, Nov. 29, 2023 -- From 2021 to 2022, there was an increase in life expectancy, which was seen for both sexes and across racial/ethnic groups, according to a November Vital Statistics Rapid Release report, a publication from the U.S. Centers for Disease Control and Prevention.
Elizabeth Arias, Ph.D., from the National Center for Health Statistics in Hyattsville, Maryland, and colleagues examined provisional life expectancy estimates for 2022 using data from the National Center for Health Statistics.
The researchers note that life expectancy at birth was 77.5 years in 2022, which was 1.1 years higher than 76.4 years in 2021. For males and females, life expectancy at birth increased to 74.8 and 80.2 years in 2022, representing increases of 1.3 and 0.9 years, respectively, from 2021. The difference in life expectancy between the sexes was 5.4 years in 2022, which marked a decrease from 5.8 years in 2021. From 2021 to 2022, life expectancy increased by 2.3, 2.2, 1.6, 1.0, and 0.8 years for the American Indian and Alaska Native non-Hispanic, Hispanic, Black non-Hispanic, Asian non-Hispanic, and White non-Hispanic populations, respectively.
"U.S. life expectancy at birth for 2022, based on near-final data, was 77.5 years, an increase of 1.1 years from 2021 (76.4 years)," the authors write. "This increase does not fully offset the loss of 2.4 years of life expectancy between 2019 and 2021 that resulted mostly from increases in excess deaths due to the COVID-19 pandemic."
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
![](/img/logo/vendor/healthday-logo.png)
© 2024 HealthDay. All rights reserved.
Posted November 2023
Read this next
AI-Assisted Contours Superior to Cognitively Defined Prostate Cancer Contours
WEDNESDAY, July 3, 2024 -- Artificial intelligence (AI)-assisted definition of prostate cancer contours reduces underestimation of the extent of prostate cancer, according to a...
Mean Cost of Bringing New Drug to U.S. Market Is $879.3 Million
TUESDAY, July 2, 2024 -- The mean cost of developing a new drug for the U.S. market is estimated to be $879.3 million when both drug development failure and capital costs are...
Patient–Primary Care Provider Language Concordance Tied to Better Outcomes
TUESDAY, July 2, 2024 -- Patient-family physician language concordance is associated with a lower risk for adverse outcomes, according to a study published online June 3...
More news resources
- FDA Medwatch Drug Alerts
- Daily MedNews
- News for Health Professionals
- New Drug Approvals
- New Drug Applications
- Drug Shortages
- Clinical Trial Results
- Generic Drug Approvals
Subscribe to our newsletter
Whatever your topic of interest, subscribe to our newsletters to get the best of Drugs.com in your inbox.